Please log in to view this page
Username
Password
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
